ROSTI, GIANANTONIO
Dettaglio
ROSTI, GIANANTONIO
G Rosti; Gianantonio Rosti; ROSTI G
Pubblicazioni
Risultati 1 - 20 di 137 (tempo di esecuzione: 0.001 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | 14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia | Mancini, Manuela; Leo, Elisa; Takemaru, Ken-Ichi; Campi, Virginia; Castagnetti, Fausto; Soverini,... Simona; De Benedittis, Caterina; Rosti, Gianantonio; Cavo, Michele; Santucci, Maria Alessandra; Martinelli, Giovanni | 2015 | PLOS ONE | 1.01 Articolo in rivista | ||
2 | ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia | Soverini S; Martinelli G; Rosti G; Bassi S; Amabile M; Poerio A; Giannini B; Trabacchi E; Castagn...etti F; Testoni N; Luatti S; de Vivo A; Cilloni D; Izzo B; Fava M; Abruzzese E; Alberti D; Pane F; Saglio G; Baccarani M. | 2005 | JOURNAL OF CLINICAL ONCOLOGY | 1.01 Articolo in rivista | - | |
3 | Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients. | Iacobucci I; Saglio G; Rosti G; Testoni N; Pane F; Amabile M; Poerio A; Soverini S; Bassi S; Cill...oni D; Bassan R; Breccia M; Lauria F; Izzo B; Merante S; Frassoni F; Paolini S; Montefusco E; Baccarani M; Martinelli G | 2006 | CLINICAL CANCER RESEARCH | 1.01 Articolo in rivista | - | |
4 | Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis | S Luatti; F Castagnetti; G Marzocchi; C Baldazzi; G Gugliotta; I Iacobucci; G Specchia; L Zanatta...; G Rege-Cambrin; M Mancini; E Abruzzese; A Zaccaria; M G Grimoldi; A Gozzetti; G Ameli; M A Capucci; G Palka; P Bernasconi; F Palandri; F Pane; G Saglio; G Martinelli; G Rosti; M Baccarani; N Testoni; on behalf of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Working Party on CML | 2012 | BLOOD | 1.01 Articolo in rivista | - | |
5 | Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr–Abl mutations and mutational analysis | Soverini S; Martinelli G.; Rosti G.; Iacobucci I.; Baccarani M. | 2012 | PHARMACOGENOMICS | 1.01 Articolo in rivista | - | |
6 | Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival | Massimo Breccia;Luigiana Luciano;Roberto Latagliata;Fausto Castagnetti;Dario Ferrero;Francesco Ca...vazzini;Malgorzata Monica Trawinska;Mario Annunziata;Fabio Stagno;Mario Tiribelli;Gianni Binotto;Elena Crisà;Pellegrino Musto;Antonella Gozzini;Laura Cavalli;Enrico Montefusco;Alessandra Iurlo;Sabina Russo;Michele Cedrone;Antonella Russo Rossi;Patrizia Pregno;Mauro Endri;Antonio Spadea;Matteo Molica;Gianfranco Giglio;Francesca Celesti;Federica Sorà;Sergio Storti;Ada D’Addosio;Giovanna Rege Cambrin;Alessandro Isidori;Simona Sica;Elisabetta Abruzzese;Giorgina Speccha;Gianantonio Rosti;Giuliana Alimena | 2014 | LEUKEMIA RESEARCH | 1.01 Articolo in rivista | - | |
7 | Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) | Simona, Bernardi; Di Palma, Andrea; Cattina, Federica; Perucca, Simone; Malagola, Michele; Tiribe...lli, Mario; Codarin, Erika; Bochicchio, MARIA TERESA; Ruggeri, Giuseppina; Franceschini, Luca; Cancelli, Valeria; Castagnetti, Fausto; Soverini, Simona; Fogli, Miriam; Venturi, Claudia; Lavorgna, Serena; Pagani, Chiara; Skert, Cristina; Zanaglio, Camilla; Turra, Alessandro; Polverelli, Nicola; Caimi, Luigi; Rossi, Giuseppe; Teresa Voso, Maria; Rosti, Gianantonio; Martinelli, Giovanni; Baccarani, Michele; Russo, Domenico | 2016 | BLOOD | 1.06 Abstract in rivista | - | |
8 | Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet. | Soverini S.; Hochhaus A.; Nicolini F.E.; Gruber F.; Lange T.; Saglio G.; Pane F.; Müller M.C.; Er...nst T.; Rosti G.; Porkka K.; Baccarani M.; Cross N.C.; Martinelli G. | 2011 | BLOOD | 1.01 Articolo in rivista | - | |
9 | BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia | Zabriskie, M.S.; Eide, C.A.; Tantravahi, S.K.; Vellore, N.A.; Estrada, J.; Nicolini, F.E.; Khoury..., H.J.; Larson, R.A.; Konopleva, M.; Cortes, J.E.; Kantarjian, H.; Jabbour, E.J.; Kornblau, S.M.; Lipton, J.H.; Rea, D.; Stenke, L.; Barbany, G.; Lange, T.; Hernandez-Boluda, J.-C.; Ossenkoppele, G.J.; Press, R.D.; Chuah, C.; Goldberg, S.L.; Wetzler, M.; Mahon, F.-X.; Etienne, G.; Baccarani, M.; Soverini, S.; Rosti, G.; Rousselot, P.; Friedman, R.; Deininger, M.; Reynolds, K.R.; Heaton, W.L.; Eiring, A.M.; Pomicter, A.D.; Khorashad, J.S.; Kelley, T.W.; Baron, R.; Druker, B.J.; Deininger, M.W.; O'Hare, T. | 2014 | CANCER CELL | 1.01 Articolo in rivista | - | |
10 | The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib | Castagnetti, Fausto; Gugliotta, Gabriele; Breccia, Massimo; Iurlo, Alessandra; Levato, Luciano; A...lbano, Francesco; Vigneri, Paolo; Abruzzese, Elisabetta; Rossi, Giuseppe; Rupoli, Serena; Cavazzini, Francesco; Martino, Bruno; Orlandi, Ester; Pregno, Patrizia; Annunziata, Mario; Usala, Emilio; Tiribelli, Mario; Sica, Simona; Bonifacio, Massimiliano; Fava, Carmen; Gherlinzoni, Filippo; Bocchia, Monica; Soverini, Simona; Bochicchio, MARIA TERESA; Cavo, Michele; Martinelli, Giovanni; Saglio, Giuseppe; Pane, Fabrizio; Baccarani, Michele; Rosti, Gianantonio | 2017 | AMERICAN JOURNAL OF HEMATOLOGY | 1.01 Articolo in rivista | - | |
11 | Charlson comorbidity index and adult comorbidity evaluation-27 might predict compliance and development of pleural effusions in elderly chronic myeloid leukemia patients treated with dasatinib after resistance/intolerance to imatinib. | Breccia M.; Latagliata R.; Stagno F.; Luciano L.; Gozzini A.; Castagnetti F.; Fava C.; Cavazzini ...F.; Annunziata M.; Russo Rossi A.; Pregno P.; Abruzzese E.; Vigneri P.; Rege-Cambrin G.; Sica S.; Pane F.; Santini V.; Specchia G.; Rosti G.; Alimena G. | 2011 | HAEMATOLOGICA | 1.01 Articolo in rivista | - | |
12 | Chibby 1: A new component of β-catenin-signaling in chronic myeloid leukemia | Mancini, Manuela; Soverini, Simona; Gugliotta, Gabriele; Santucci, MARIA ALESSANDRA; Rosti, Giana...ntonio; Cavo, Michele; Martinelli, Giovanni; Castagnetti, Fausto | 2017 | ONCOTARGET | 1.01 Articolo in rivista | - | |
13 | Choosing the Best Second-Line Tyrosine Kinase Inhibitor in Imatinib-Resistant Chronic Myeloid Leukemia Patients Harboring Bcr-Abl Kinase Domain Mutations: How Reliable Is the IC50? | Soverini S; Rosti G; Iacobucci I; Baccarani M; Martinelli G. | 2011 | THE ONCOLOGIST | 1.01 Articolo in rivista | - | |
14 | Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications. | Zaccaria A; Testoni N; Valenti AM; Luatti S; Tonelli M; Marzocchi G; Cipriani R; Baldazzi C; Gian...nini B; Stacchini M; Gamberini C; Castagnetti F; Rosti G; Azzena A; Cavazzini F; Cianciulli AM; Dalsass A; Donti E; Giugliano E; Gozzetti A; Grimoldi MG; Ronconi S; Santoro A; Spedicato F; Zanatta L; Baccarani M | 2010 | CANCER GENETICS AND CYTOGENETICS | 1.01 Articolo in rivista | - | |
15 | Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up | Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungo...lino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G; GIMEMA Working Party on Chronic Myeloid Leukemia | 2008 | HAEMATOLOGICA | 1.01 Articolo in rivista | - | |
16 | Chronic myeloid leukemia. Drug selection in first-line therapy and beyond | Gianantonio, Rosti; Gabriele, Gugliotta; Fausto, Castagnetti | 2014 | HEMATOLOGY EDUCATION | 1.01 Articolo in rivista | - | |
17 | Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response, a study of the GIMEMA CML WP. | Testoni N; Marzocchi G; Luatti S; Amabile M; Baldazzi C; Stacchini M; Nanni M; Rege-Cambrin G; Gi...ugliano E; Giussani U; Abruzzese E; Kerim S; Grimoldi MG; Gozzetti A; Crescenzi B; Carcassi C; Bernasconi P; Cuneo A; Albano F; Fugazza G; Zaccaria A; Martinelli G; Pane F; Rosti G; Baccarani M. | 2009 | BLOOD | 1.01 Articolo in rivista | - | |
18 | Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type | Baccarani M.; Rosti G.; Soverini S. | 2019 | LEUKEMIA | 1.01 Articolo in rivista | - | |
19 | Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment. | IACOBUCCI I; ROSTI G; AMABILE M; POERIO A; SOVERINI S; CILLONI D; TESTONI N; ABRUZZESE E; MONTEFU...SCO E; OTTAVIANI E; IULIANO F; RUSSO D; GOBBI M; ALIMENA G; MARTINO B; TERRAGNA C; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G | 2006 | JOURNAL OF CLINICAL ONCOLOGY | 1.01 Articolo in rivista | - | |
20 | Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of patients with high risk, Philadelphia-positive, chronic myeloid leukaemia: a European LeukemiaNet study | Baccarani M; Rosti G; Castagnetti F; Haznedaroglu I; Porkka K; Abruzzese E; Alimena G; Ehrencrona... H; Hjorth-Hansen H; Kairisto V; Levato L; Martinelli G; Nagler A; Nielsen JL; Ozbek U; Palandri F; Palmieri F; Pane F; Rege-Cambrin G; Russo D; Specchia G; Testoni N; Weiss-Bjerrum O; Saglio G; Simonsson B. | 2009 | BLOOD | 1.01 Articolo in rivista | - |